Bladder Adaptive Radiotherapy (BART) Trial - A study on the feasibility of BART.
Phase 1
- Conditions
- Bladder CancerCancer - Bladder
- Registration Number
- ACTRN12613000774729
- Lead Sponsor
- Royal Prince Alfred Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Aged 18 years or older
Histologically confirmed muscle invasive bladder cancer (any pathology)
Stage T2-3b N0 M0
Considered suitable for definitive radiotherapy with or without concurrent chemotherapy
Has provided written Informed Consent for participation in this trial
An ECOG performance status score of 2 or less
Life expectancy greater than 5 years
Participants capable of childbearing are using adequate contraception
Available for follow up
Exclusion Criteria
Other active malignancy
Previous pelvic radiotherapy
Clinical or radiological evidence of nodal or distant metastases
Women who are pregnant or lactating
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method